Disseminated strongyloidiasis complicating glioblastoma therapy: A case report

Dawit Aregawi, David Lopez, Mark Wick, W. Michael Scheld, David Schiff

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Strongyloides stercoralis is an intestinal parasite that can cause fatal opportunistic infections in immunocompromised patients. Here we report an immunocompromised patient with glioblastoma who developed disseminated strongyloidiasis 6 weeks after completion of standard radiotherapy and concurrent temozolomide chemotherapy. She was effectively treated with albendazole and ivermectin. Strongyloidiasis should be considered in patients being treated for glioma who have lived or traveled to high risk areas and developed gram negative sepsis, along with gastrointestinal or respiratory symptoms, skin rash or SIADH.

Original languageEnglish (US)
Pages (from-to)439-443
Number of pages5
JournalJournal of neuro-oncology
Volume94
Issue number3
DOIs
StatePublished - Apr 8 2009

All Science Journal Classification (ASJC) codes

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Fingerprint Dive into the research topics of 'Disseminated strongyloidiasis complicating glioblastoma therapy: A case report'. Together they form a unique fingerprint.

Cite this